These authors extrapolated their findings by applying multiplex immunofluorescent staining to show that RUNX1 was expressed in human breast cancer fibroblasts but not in normal breast tissue, while a RUNX1-stromal signature could stratify patients. Here, RUNX1 is linked to breast cancer.